Filing Details
- Accession Number:
- 0000905148-24-000991
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-20 16:18:21
- Reporting Period:
- 2024-03-18
- Accepted Time:
- 2024-03-20 16:18:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1228627 | Ocuphire Pharma Inc. | OCUP | Pharmaceutical Preparations (2834) | 113516358 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1999390 | George Magrath | C/O Ocuphire Pharma, Inc. 37000 Grand River Ave, Suite 120 Farmington Hills MI 48335 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-18 | 25,000 | $1.96 | 425,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.90 to $1.99, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
